Evidence map›Paper›PMID 32295932›Full record

ArticleSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection.

Airu Liu, Yuxin Wang, Yingxiao Song, Yiqi Du

Open access · diamondAbstract read
In one paragraph

Article in Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Third-line and rescue therapy for refractoryWorld journal of gastroenterology · 2023
    Pooled it
  2. Evaluation of efficacy and safety ofFrontiers in immunology · 2024
    Trial
  3. Article
  4. Beyond Antibiotics: Alternative Strategies TargetingExpert reviews in molecular medicine · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Treatment of refractoryFrontiers in microbiology · 2022
    Review
  10. Rescue effects ofNew microbes and new infections · 2021
    Article
  11. Strategies forSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Airu LiuDepartment of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Yuxin WangDepartment of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Yingxiao SongDepartment of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Yiqi DuDepartment of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimTreatment of Helicobacter pylori infections has become more difficult because of increasing antibiotic resistance. We assessed the efficacy and safety of treatment with probiotics followed by a tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for H. pylori infection. PATIENTS AND

methodsThis retrospective study examined patients with at least two H. pylori eradication failures. Patients were given a two-week compound Lactobacillus acidophilus (1 g t.i.d.), followed by a quadruple antibiotic regimen (esomeprazole [20 mg b.i.d.] + bismuth potassium citrate [220 mg b.i.d.] + tetracycline [750 mg b.i.d.] + furazolidone [100 mg b.i.d.]) for 10 days as rescue therapy. Eradication was evaluated using the

resultsThe records of 50 patients were examined. Four cases experienced treatment failure, and one case received replacement with metronidazole because of allergy to furazolidone. The eradication rate was 92.0% [95% confidence interval (CI): 84.0-98.0%) in intention-to-treat (ITT) analysis and 91.8% (95% CI: 83.7-98.0%) in per protocol (PP) analysis. Side effects (mainly dizziness, dry mouth, and skin rash) occurred in 10 patients, all of which resolved after cessation of antibiotics.

conclusionsPatients who failed multiple attempts at H. pylori eradication may benefit from a treatment with probiotics followed by a tetracycline- and furazolidone-containing quadruple regimen.

Indexed as

Anti-Bacterial AgentsFurazolidoneHelicobacter InfectionsProbioticsTetracyclineDrug Therapy, CombinationHumansLactobacillus acidophilusRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsFurazolidoneTetracyclineEfficacyfurazolidoneHelicobacter pyloriprobioticssafetytetracycline

Identifiers

PMID32295932
PMCPMC7279076
OpenAlexW3016939167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.